NEWSROOM

GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Extension of Agreement with PeaceHealth Sacred Heart Medical Center at RiverBend

GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Extension of Agreement with PeaceHealth Sacred Heart Medical Center at RiverBend

Extended 10-year Agreement to Upgrade Gamma Knife® Perfexion™ with Elekta Esprit San Francisco, CA, June 7, 2024 – GK Financing LLC (GKF), a subsidiary of American Shared Hospital Services (NYSE American: AMS), a leading provider of turnkey technology solutions for advanced radiosurgery and radiation oncology services, announced today that it has extended its current agreement with PeaceHealth Sacred Heart Medical Center at RiverBend in Springfield, Ore. The new agreement will see the center...

read more
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study

New York, June 3, 2024—Oncocyte’s (Nasdaq: OCX) VitaGraft Kidney™ diagnostic test for transplant monitoring has shown promising results in a Phase 2 clinical trial, published in the prestigious New England Journal of Medicine. The trial evaluated the test's effectiveness in monitoring graft health in patients with antibody-mediated rejection (AMR), a leading cause of kidney transplant failure. The study's positive outcomes highlight new clinical uses for VitaGraft Kidney, including therapeutic...

read more
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Clinical testing of LP-310 expected to commence in mid-2024    Patient recruitment is underway for Phase 2a multicenter, dose-ranging study PITTSBURGH, PA., May 31, 2024 -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the successful completion of its first Site Initiation Visit (SIV) for the Phase 2a trial evaluating LP-310 in the treatment...

read more
SS Innovations Engages BDO as its new Auditor

SS Innovations Engages BDO as its new Auditor

SS Innovations believes that the selection of BDO will facilitate uplisting of its common stock to a National Securities Exchange and reflects the Company’s commitment to transparent financial and accounting practices and regulatory compliance FORT LAUDERDALE, Fla., May 31, 2024 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to...

read more
AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

Hauppauge, NY, May 30, 2024 - AmpliTech Group, Inc.  (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, announced today that it received a notice from the Nasdaq Stock Market, stating the Company has regained compliance with Nasdaq’s periodic filing...

read more
BioStem Technologies to Sponsor MRO Better Half Dash

BioStem Technologies to Sponsor MRO Better Half Dash

POMPANO BEACH, Fla., May 29, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics, will sponsor the MRO Better Half Dash which will be held on May 29, 2024, from 4:00 PM – 9:00 PM at the Trackhouse Motorplex, 130 Motorplex Dr, Mooresville, NC. The Better Half Dash has become a beloved annual event in NASCAR, eagerly anticipated by fans and participants alike. Billy...

read more
UAV CORP’S, SKYBORNE TECHNOLOGY, Announces the Official Grand Opening of a New Office and HANGER located AT ITS WHOLLY OWNED AIRPORT IN GULF COUNTY, FLORIDA

UAV CORP’S, SKYBORNE TECHNOLOGY, Announces the Official Grand Opening of a New Office and HANGER located AT ITS WHOLLY OWNED AIRPORT IN GULF COUNTY, FLORIDA

SKYBORNE TECHNOLOGY PREPARES FOR First Launch with a Helium LIFT CHECK FOR its NEW SA70-12 AIRSHIP Port St. Joe, Florida:  May 29, 2024 - Skyborne Technology, Inc. (STI), a UAV Corp subsidiary (OTC Pink: UMAV) announces the grand opening of its new office and hangar located at its wholly owned airport in Gulf County, Florida, paving the road for upcoming advanced testing and flight operations for manned and unmanned vehicles. The newest addition, the DART SA 70-12; the only semi-rigid...

read more
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Abstract highlighting new preclinical data from LP-50 in non-muscle invasive bladder cancer PITTSBURGH, Pa., May 29, 2024 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces an abstract publication at the 2024 American Society of Clinical Oncology (ASCO) annual meeting, taking place from May 31 - June 4 in Chicago, IL, and online. Lipella’s...

read more
BranchOut Food Successfully Completes Key Tests with U.S. Army, Advancing MREs with GentleDry Technology

BranchOut Food Successfully Completes Key Tests with U.S. Army, Advancing MREs with GentleDry Technology

Live troop field tests mark the final phase in integrating GentleDry technology into military rations BEND, Ore., May 28, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, has completed a successful shelf-life test through a strategic collaboration with the U.S. Army Combat Capabilities Development Command (DEVCOM) to enhance Meals Ready-to-Eat or MREs utilizing BranchOut Food’s proprietary GentleDry...

read more
AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

AmpliTech Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Hauppauge, NY, May 24, 2024 -  AmpliTech Group, Inc.  (Nasdaq: AMPG, AMPGW), announced today that it received a notice of non-compliance from the Nasdaq Stock Market on May 22, 2024 notifying the company that, as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024, the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all periodic...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850